Annual rank61
Croatia · Consumer Non-Cyc.
Podravka
Podravka Group’s portfolio includes Vegeta, Dolcela, Lino, Žito, Neofen and Belje among its brands.
FY2022–FY2025
FY2022–FY2025
FY2022–FY2025
current context only
Company profile
From Koprivnica pantry brands to factories, fields and pharmacies
Podravka is a Croatian group with three linked but distinct businesses: branded food, Belupo pharmaceuticals and Podravka Agri. Its shelves stretch from Vegeta seasoning, Čokolino cereal and Lino Lada spreads to Eva fish products; behind them sit factories, pharmaceutical production, farms and a wide distribution network. A 1947 Koprivnica food business has become an international platform whose strategy through 2030 still places brands, production capacity and domestic raw materials at the centre.
Across the pantry
Seasoning, cereal, spreads and fish serve different eating occasions
Vegeta began in 1959 as a dried-vegetable-and-spice seasoning and now extends into Natur, BIO, paste and liquid formats. Čokolino is a cereal meal with Plus and Fit variants; Lino Lada runs from Duo to Milk, Coconut and Gold spreads. Eva adds canned and frozen fish, pâtés and ready-to-eat salads. This is a portfolio organised by eating occasion, not one flagship alone. By the July 2026 H1 report, Podravka had reported Lino Lada listings in about 1,650 Penny stores nationally and about 900 Lidl stores in Baden-Württemberg and Bavaria. This shows distribution, not consumer sell-through.
- Map Lino Lada on German shelves Penny national and Lidl regional listings, with no sell-through claim
- Open the Vegeta range Original, Natur, BIO, paste and liquid seasoning formats
- Meet Čokolino The cereal line and its Plus and Fit variants
- Compare Lino Lada spreads Duo, Milk, Coconut and Gold recipes in the official range
- Browse Eva fish products Canned and frozen fish, pâtés and prepared salads
Factory and logistics system
New lines and a logistics-distribution centre changed the industrial backbone
Podravka's completed investment cycle put nearly €250 million into a pasta factory, tomato-processing plant, 11 production lines, 15 packaging lines, a solar plant and a logistics-distribution centre. The factory gallery adds Kalnik fruit-and-vegetable production and Žito's Maribor bakery; employee profiles describe an automated, robotised Vegeta, Soups and Pasta Factory. Factory-level BRC, HACCP, halal and kosher certificates sit behind those assets.
- See the completed investment cycle New plants, production lines, solar power and logistics
- View the production sites Official factory images from Koprivnica, Varaždin and Maribor
- Read from the factory floor Automation, robotisation and energy projects in employee profiles
- Check factory certificates Named plants and their food-safety or market certifications
Three business pillars
The operating map now runs from fields to pharmacy shelves
Food now sits beside Belupo pharmaceuticals and Podravka Agri. Belupo develops, produces and sells prescription, over-the-counter and dermatological products. Agriculture pages identify Belje, PIK Vinkovci and Vupik; Belje's operations span arable and seed production, animal feed, pig and cattle farms, dairies, cured meats, vineyards and a winery. The group therefore reaches from raw-material production to retailer and pharmacy shelves.
- See the three-pillar group Food, Pharmaceuticals and Agriculture in the FY2025 review
- Inside Belupo Prescription, over-the-counter and dermatological products
- Map the agriculture segment Belje, PIK Vinkovci and Vupik within Podravka Agri
- Explore Belje's operations Crops, livestock, feed, dairy, cured meats and wine
From Koprivnica outward
A fruit workshop became a five-continent export system
Podravka traces its origin to the Wolf brothers' Koprivnica fruit-and-jam workshop, which became Podravka in 1947. Soups followed in 1957, Vegeta in 1959 and exports first to Hungary and Russia. The group now reports markets in more than 60 countries; nearly 70% of 2024 food revenue came from international markets. Its 2030 strategy targets further brand expansion in Germany, Austria, Switzerland, the USA and Australia.
- Trace the company history The 1947 workshop, early products and first export markets
- Open the market map The issuer's current country footprint across five continents
- Read the 2024 export picture International food revenue and growth markets
- Follow the strategy through 2030 Priority brands, markets, capacity and domestic raw materials
Official profile sources: History | Podravka · About us | Podravka
Current 2026 update
What is changing at Podravka in 2026?
Podravka's three pillars are becoming tangible in different places: Lino Lada on German shelves, Podravka Agri moving crops through silos and factories, and Belupo planning a dermatology-led investment cycle.
The change in one sentence
Food, Agriculture and Pharmaceuticals now have distinct 2026 proof points.
Distribution is live, the Agri operating footprint is measurable and Belupo's dermatology platform remains a planned programme rather than completed capacity.
Four lenses on 2026
The same four-quadrant format used in the Company profile.
01 · Food internationalisation
Lino Lada lands on German shelves through two different listings
Penny carries Lino Lada Duo, Milk, Gold and Coconut in about 1,650 stores nationwide in Germany. Lidl has added Duo and Milk in about 900 stores in Baden-Württemberg and Bavaria, a regional listing with a different scope. Together, the two issuer-reported approximate counts total roughly 2,550 store listings. Podravka's March release covered the initial Penny step; the July H1 report added Lidl. The company describes further distribution within the Rewe and Schwarz retail groups only as potential. Neither source reports sell-through, repeat orders or consumer uptake, so the listing is evidence of availability rather than commercial success.
- Current signalPenny about 1,650 stores nationally · Lidl about 900 stores in two regions · different scopes
- Why it mattersA stated internationalisation strategy now has a checkable shelf map, while demand and broader rollout remain open.
- H1 operating and segment review Podravka · 23 July 2026
- Initial Penny listing Podravka · 25 March 2026
02 · Agriculture in operation
Fields, four silos and a factory make the new Agri pillar visible
Belje, Vupik and PIK Vinkovci harvested barley and wheat across more than 9,000 hectares. Podravka reports a record barley yield of 7.9 tonnes per hectare, 7% above the prior year, and above-plan wheat yields. Silos in Darda, Beli Manastir, Vukovar and Vinkovci stored more than 140,000 tonnes of grain and received over 350 trucks a day at peak. Separately, more than 550 tonnes of peas moved from fields around Koprivnica to the Varaždin factory within hours; the company says peas, beetroot and tomatoes are self-sufficient crops. This scale did not remove livestock pressure: pig and milk prices reduced H1 Agri EBITDA by EUR7.0m and EUR2.2m respectively, largely offset by process and operating-model changes, with normalised EBITDA still down 10.7% versus the 2025 pro forma base.
- Current signal>9,000 ha · barley 7.9 t/ha · >140,000 tonnes stored · >350 trucks/day at peak
- Why it mattersThe acquired Agri pillar now has a visible field-to-silo-to-factory system, but crop execution and livestock economics are not the same thing.
- Agri harvest and silo logistics Podravka · 22 July 2026
- H1 operating and segment review Podravka · 23 July 2026
03 · Pharmaceuticals
Belupo grows current categories while planning a dermatology platform
Belupo's H1 pharmaceutical revenue rose 7.1% to EUR94 million against the 2025 pro forma base. Own-brand sales grew 5.8%, led mainly by OTC and nervous-system medicines in Eastern Europe and Croatia. The 2030 strategy is a separate future-state claim: it aims for European leadership in dermatology and regional strength in OTC, cardiology, psychiatry and neurology, with Western expansion through dermatology and partnerships. The strategy includes EUR36 million of planned investment to expand production and logistics, improve efficiency and create a Dermatology Centre of Excellence. The source does not show that Centre as complete or quantify new capacity, and current category growth does not establish the targeted future market position.
- Current signalH1 Pharma revenue +7.1% · own brands +5.8% · EUR36m planned investment
- Why it mattersThe distinction separates what Belupo is already selling from the platform and position it is only planning to build.
- H1 operating and segment review Podravka · 23 July 2026
- H1 three-segment update Podravka · 23 July 2026
- Belupo dermatology investment plan Podravka · 16 June 2025
04 · What to watch
Three questions for the next disclosures
The next disclosures should distinguish listings from demand, crop logistics from livestock margins and planned pharmaceutical capacity from completed assets.
- German distributionDoes Lidl extend beyond two regions, or do Penny and Lidl add variants or provide sell-through evidence?
- Agri economicsHow far do process and operating-model changes offset pig and milk price pressure as the field-to-factory system scales?
- Dermatology build-outHow much of the EUR36 million programme appears as disclosed capacity, headcount or Centre-of-Excellence progress?
Annual record
Ranking history
Future editions add rows; they do not rewrite the 2026 record.
| Edition | Measurement period | Rank | Revenue growth | Net-income growth | Stock return |
|---|---|---|---|---|---|
| 2026 | FY2022–FY2025 | 61 | +56% | +176% | +91% |